A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's Disease

被引:2
|
作者
Irwin, James [1 ,2 ,3 ]
Lord, Anton [1 ]
Ferguson, Emma [2 ]
Simms, Lisa A. [1 ]
Hanigan, Katherine [1 ]
Montoya, Carlos A. [4 ,5 ]
Radford-Smith, Graham [1 ,2 ,6 ]
机构
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Palmerston North Hosp, Dept Gastroenterol, 50 Ruahine St, Palmerston North 4442, New Zealand
[4] AgResearch Ltd, Te Ohu Rangahau Kai Facil, Smart Foods Innovat Ctr Excellence, Palmerston North 4474, New Zealand
[5] Massey Univ, Riddet Inst, Te Ohu Rangahau Kai Facil, Palmerston North 4474, New Zealand
[6] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia
关键词
Biomarkers; Crohn's disease; Inflammatory bowel diseases; Stenosis; Perforation; Fistula; MAINTENANCE THERAPY; NATURAL-HISTORY; INDUCTION; RESECTION; COHORT; METHOTREXATE; PROGRESSION; ADALIMUMAB; REMISSION; SURGERY;
D O I
10.1007/s10620-022-07639-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn's disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes. Aims To study the correlation between longitudinal laboratory testing and subsequent intestinal complications in patients with Crohn's disease. Methods An observational cohort of patients with Crohn's disease at a single center were analyzed between 01/01/1994 and 06/30/2016. A complication was defined as the development of an intestinal fistula, stenosis, or perforation. Exploratory analysis using Cox regression was performed to select the best statistical method to represent longitudinal laboratory data. Cox regression was used to identify laboratory variables independently associated with the development of a subsequent complication. A clinical scoring tool was designed. Results In 246 patients observed over a median of 5.72 years, 134 complications occurred. Minimum or maximum value in a preceding window period of one year was most strongly associated with subsequent complication. A Longitudinal Laboratory score of >= 2 (maximum albumin level < 39 g/L = 1, maximum mean cell volume < 88 fL = 1, minimum platelet count > 355 x 10(9)/L = 1, minimum C reactive protein > 5 mg/L = 1) was 62% sensitive and 91% specific in identifying patients who develop a subsequent complication. Conclusion A consistent reduction in serum albumin and mean cell volume, and a consistent increase in platelet count and C reactive protein were associated with a subsequent complication in patients with Crohn's disease. Longitudinal laboratory tests may be used as described in this paper to provide a rational for earlier escalation of therapy.
引用
收藏
页码:596 / 607
页数:12
相关论文
共 50 条
  • [1] A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease
    James Irwin
    Anton Lord
    Emma Ferguson
    Lisa A. Simms
    Katherine Hanigan
    Carlos A. Montoya
    Graham Radford-Smith
    Digestive Diseases and Sciences, 2023, 68 : 596 - 607
  • [2] Intestinal perforation: an unusual complication of the intestinal tuberculosis that simulated Crohn's disease
    Sarabia, MTF
    Escarcena, AC
    Lora, FAR
    Cruz, MAR
    Tobajas, VME
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (07) : 536 - 537
  • [3] Rare complication of intestinal Crohn's disease: giant fibroid polyp
    U. Korman
    S. Kuruoglu
    S. Haider
    European Radiology, 2000, 10 : 435 - 437
  • [4] Intestinal Failure: A Small but Imperfectly Phenotyped Complication of Crohn's Disease
    Mehta, Shameer
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (12): : 1895 - 1896
  • [5] Rare complication of intestinal Crohn's disease: giant fibroid polyp
    Korman, U
    Kuruoglu, S
    Haider, S
    EUROPEAN RADIOLOGY, 2000, 10 (03) : 435 - 437
  • [6] Intestinal cancer in patients with Crohn’s disease
    Sabine Kersting
    Matthias Bruewer
    Mike G. Laukoetter
    Emile M. Rijcken
    Rudolf Mennigen
    Horst Buerger
    Norbert Senninger
    Christian F. Krieglstein
    International Journal of Colorectal Disease, 2007, 22 : 411 - 417
  • [7] Intestinal cancer in patients with Crohn's disease
    Kersting, Sabine
    Bruewer, Matthias
    Laukoetter, Mike G.
    Rijcken, Emile M.
    Mennigen, Rudolf
    Buerger, Horst
    Senninger, Norbert
    Krieglstein, Christian F.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (04) : 411 - 417
  • [8] Intestinal permeability in patients with Crohn's disease
    Benjamin, Jaya
    Makharia, Govind K.
    Ahuja, Vineet
    Kalaivani, M.
    Joshi, Yogendra K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A418 - A418
  • [9] Do Changes in Intestinal Permeability Predict Disease Relapse in Crohn's Disease?
    Vogelsang, H.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S162 - S163
  • [10] Patients with Crohn's disease with intestinal failure have less active disease than patients with Crohn's disease without intestinal failure
    Bouri, S.
    Willsmore, J.
    Geldof, J.
    Gabe, S.
    Donnelly, S.
    Hart, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S591 - S592